Correlation Between Amicus Therapeutics and Rapport Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Amicus Therapeutics and Rapport Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amicus Therapeutics and Rapport Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amicus Therapeutics and Rapport Therapeutics, Common, you can compare the effects of market volatilities on Amicus Therapeutics and Rapport Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amicus Therapeutics with a short position of Rapport Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amicus Therapeutics and Rapport Therapeutics,.
Diversification Opportunities for Amicus Therapeutics and Rapport Therapeutics,
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Amicus and Rapport is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Amicus Therapeutics and Rapport Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rapport Therapeutics, and Amicus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amicus Therapeutics are associated (or correlated) with Rapport Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rapport Therapeutics, has no effect on the direction of Amicus Therapeutics i.e., Amicus Therapeutics and Rapport Therapeutics, go up and down completely randomly.
Pair Corralation between Amicus Therapeutics and Rapport Therapeutics,
Given the investment horizon of 90 days Amicus Therapeutics is expected to generate 0.29 times more return on investment than Rapport Therapeutics,. However, Amicus Therapeutics is 3.45 times less risky than Rapport Therapeutics,. It trades about -0.15 of its potential returns per unit of risk. Rapport Therapeutics, Common is currently generating about -0.29 per unit of risk. If you would invest 984.00 in Amicus Therapeutics on October 24, 2024 and sell it today you would lose (43.00) from holding Amicus Therapeutics or give up 4.37% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Amicus Therapeutics vs. Rapport Therapeutics, Common
Performance |
| Timeline |
| Amicus Therapeutics |
| Rapport Therapeutics, |
Amicus Therapeutics and Rapport Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Amicus Therapeutics and Rapport Therapeutics,
The main advantage of trading using opposite Amicus Therapeutics and Rapport Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amicus Therapeutics position performs unexpectedly, Rapport Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rapport Therapeutics, will offset losses from the drop in Rapport Therapeutics,'s long position.| Amicus Therapeutics vs. Incyte | Amicus Therapeutics vs. Denali Therapeutics | Amicus Therapeutics vs. argenx NV ADR | Amicus Therapeutics vs. Harmony Biosciences Holdings |
| Rapport Therapeutics, vs. Genesco | Rapport Therapeutics, vs. Skechers USA | Rapport Therapeutics, vs. Bridgford Foods | Rapport Therapeutics, vs. Sysco |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |